Home / Market News / $PLYX

$PLYX news and market catalysts

The 2 most recent market catalysts affecting $PLYX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 0 high impact 0 bullish 0 bearish Biotechnology

Aug 13, 2026 Corporate Catalyst Neutral Impact 65

Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6

Raymond James has initiated coverage on Polaryx Therapeutics (PLYX) with a 'Strong Buy' rating and a $6 price target. This is a significant event for a smaller biotechnology compan…

Jul 27, 2026 Corporate Catalyst Neutral Impact 65

LUCID CAPITAL MARKETS Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7

Lucid Capital Markets initiating coverage on Polaryx Therapeutics with a 'Buy' rating and a $7 price target is a significant event for the company. Analyst coverage often brings in…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.